Ching-Wei Chang Selected Research

Zidovudine (Retrovir)

3/2014	Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine.
3/2011	XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Wei Chang Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 11/2005
5	Triple Negative Breast Neoplasms 01/2022 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 03/2011
4	Chemical and Drug Induced Liver Injury 08/2016 - 01/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
2	Disease Progression 01/2022 - 10/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
2	Diarrhea 05/2021 - 01/2018
2	Inflammation (Inflammations) 05/2021 - 06/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Adenocarcinoma 01/2020 - 01/2018
2	Renal Insufficiency (Renal Failure) 08/2019 - 01/2011
2	Chronic Renal Insufficiency 08/2019 - 11/2012
2	Disease Susceptibility (Diathesis) 01/2013 - 01/2012
2	Polyps 11/2011 - 08/2010
1	Bites and Stings (Sting) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Body Weight (Weight, Body) 05/2021
1	Mucositis 05/2021
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Lymphatic Metastasis 03/2020
1	Hepatitis C 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Simpson-Golabi-Behmel syndrome 06/2015
1	Obesity 01/2015
1	Weight Gain 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2014
1	Gallstones (Gallstone) 04/2013
1	Cholelithiasis 04/2013
1	End Stage Liver Disease 11/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2012
1	Carcinoma (Carcinomatosis) 06/2012
1	Necrosis 06/2012
1	Fibrosis (Cirrhosis) 01/2011
1	Stomach Ulcer (Gastric Ulcer) 08/2010

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 08/2016 - 01/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
5	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 06/2012
4	atezolizumabIBA 11/2020 - 01/2019
3	Fluorouracil (Carac)FDA LinkGeneric 05/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	CytokinesIBA 05/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2019
2	B7-H1 AntigenIBA 11/2020 - 01/2019
2	Leucovorin (Folinic Acid)FDA Link 01/2020 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 01/2018
2	FructoseIBA 06/2015 - 01/2015
2	Zidovudine (Retrovir)FDA LinkGeneric 03/2014 - 03/2011
1	entrectinibIBA 01/2022
1	venetoclaxIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	InterferonsIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	Plant Preparations (Preparation, Plant)IBA 05/2021
1	PlatinumIBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	Bevacizumab (Avastin)FDA Link 11/2020
1	monomethyl auristatin EIBA 11/2020
1	Sorafenib (BAY 43-9006)FDA Link 03/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	LigandsIBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Chemokine CXCL10IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 06/2015
1	Glucose (Dextrose)FDA LinkGeneric 06/2015
1	NucleosidesIBA 03/2014
1	Reverse Transcriptase InhibitorsIBA 03/2014
1	Interleukin-18 (Interleukin 18)IBA 04/2013
1	CreatinineIBA 11/2012
1	BilirubinIBA 11/2012
1	brassIBA 06/2012
1	furanIBA 06/2012
1	PyrimidinesIBA 06/2012
1	PurinesIBA 06/2012
1	CarcinogensIBA 06/2012
1	XenobioticsIBA 01/2012
1	PlasticsIBA 08/2010

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2005
4	Drug Therapy (Chemotherapy) 05/2021 - 01/2018
2	Folfox protocol 01/2020 - 01/2018
1	Immunotherapy 11/2020
1	Radiotherapy 03/2020
1	Fecal Microbiota Transplantation 01/2020
1	Contraindications 08/2019
1	Adjuvant Chemotherapy 01/2019
1	Precision Medicine 01/2012
1	Ligation 11/2011
1	Liver Transplantation 01/2011